LOC728661 Activators, also known as Solute Carrier Family 35 Member E2B (SLC35E2B), constitute a specific class of chemical compounds or molecules that have piqued the interest of researchers within the realm of molecular biology and cellular research. These activators are designed or discovered with the explicit aim of modulating the activity of the LOC728661 gene, which encodes the SLC35E2B protein. SLC35E2B belongs to the solute carrier (SLC) superfamily of transporters and plays a role in facilitating the movement of molecules across cellular membranes.
The study of LOC728661 activators holds significant promise as it enables researchers to explore the precise role of the LOC728661 gene and its encoded protein, SLC35E2B, in cellular physiology and molecular mechanisms related to membrane transport processes. Activation of LOC728661 can offer valuable insights into its potential involvement in the translocation of specific molecules across cellular membranes, contributing to our understanding of cellular homeostasis and various metabolic pathways. By manipulating the activity of LOC728661 through these activators, scientists aim to gain a deeper understanding of the complex molecular pathways and cellular functions that rely on this gene product, thereby contributing to the broader knowledge of gene regulation and cellular behavior. Consequently, LOC728661 activators serve as essential tools for researchers dedicated to unraveling the intricate molecular mechanisms that underlie cellular biology and the specific roles played by individual genes in these processes, particularly within the context of membrane transport and cellular metabolism.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
May regulate gene expression through its receptors, potentially affecting genes involved in glycosylation, such as SLC35E2B. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Can modulate gene expression via the vitamin D receptor, which may influence SLC35E2B expression. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMP-activated protein kinase, which may modulate transcriptional activity and influence SLC35E2B expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As an isoflavone with potential epigenetic effects, it may impact the expression of glycosylation-related genes like SLC35E2B. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
May activate Nrf2 pathway, which can influence gene expression, potentially including SLC35E2B. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
An HDAC inhibitor, it could lead to histone hyperacetylation, potentially enhancing SLC35E2B transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenol that may modulate various signaling pathways, potentially affecting SLC35E2B expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known to affect numerous signaling pathways, it could modulate the expression of genes like SLC35E2B. | ||||||
L-phenylephrine | 59-42-7 | sc-295315 sc-295315A | 5 g 25 g | $181.00 $492.00 | 2 | |
As an α1-adrenergic receptor agonist, it may activate signaling pathways influencing SLC35E2B expression. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Inhibits cyclin-dependent kinases and might alter cell cycle-related transcriptional programs, potentially impacting SLC35E2B levels. | ||||||